The Evolution of KOL Engagement: From Traditional Approaches to Data-Driven Insights
Pharma companies aiming to introduce the next big therapeutic innovations need fresh, innovative strategies to market their products. Engaging with Key Opinion Leaders (KOLs) for feedback and endorsement has long been an effective tactic. While traditional methods have served the industry well, the landscape is shifting: data is now driving the evolution of KOL engagement, with pharma-tech companies like Neolytica leading the way.